Clinical TrialsSearch results
Number of results: 819
Completed
- A Ph2, randomized, double-blind, dose finding study to describe the immunogenicity, safety and tolerability of VN-0200 in Japanese adults aged 60-80 years
- Prevention of respiratory syncytial viral infection
- Inoguchi Akihiro
- 2022-09-08
Completed
- A pharmacokinetic study of NPC-15 Tablet (for adult use)
- Sleep-onset difficulty associated with mild cognitive impairment or dementia
- Eto Takashi
- 2023-03-02
Other
- A Pharmacokinetic Trial of the OPB-111077 Current Formulation Versus the Modified Formulation by Single Administration in Healthy Adult Male Subjects
- Diffuse large B-cell lymphoma
- Sanada Nobuhito
- 2023-06-27
Recruiting
- A Phase 1 Drug-drug Interaction Study of Ensitrelvir with Itraconazole or Carbamazepine in Healthy Adult Participants
- COVID-19
- Gomez Juan Carlos
- 2023-08-04
Completed
- A Phase 1 Mass Balance Study of Oral [14C] TAS-115 in Healthy Adult Male Subjects
- Chronic fibrosing interstitial lung diseases with a progressive phenotype
- Huang Jinhong
- 2021-09-07
Completed
- A phase 1 open-label study evaluating the effects of food on TAS-205 in healthy volunteers
- Duchenne Muscular Dystrophy
- Takeda Shin'ichi
- 2023-06-25
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Axatilimab When Administered by Intravenous Infusion to Healthy Japanese Participants
- GVHD, healthy voluteer
- Ono Shintaro
- 2023-02-27
Completed
- A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB054707 When Administered Orally to Healthy Japanese Participants
- Inflammatory disease
- On Shintaro
- 2021-10-18
Other
- A Phase 1, open label study to evaluate the pharmacokinetics, safety and tolerability of single subcutaneous dose amlitelimab in healthy adult participants.
- Healthy adult participants
- Tanaka Tomoyuki
- 2022-08-31
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21